Unichem Ghana Group, a leading name in Pharmaceutical Marketing & Distribution, has received an endorsement from the Ghana Society of Dermatology for ‘Mycolex Cream & Mycolex Powder’.
Mycolex Cream & Mycolex Powder contain Miconazole, which is a broad spectrum anti-fungal useful in the treatment of skin fungal infections like athletes’s foot, ringworm etc.
At the official signing at Unichem Head office, delegates from the Society including the President were welcomed by Country Manager of LUEX, Mr. Ranjeet Jamdar, and Senior Pharmacist of Unichem Ghana, Solomon Odamtten. Also present was Chairman of the Group, Mr. Raj Mohan, and other senior members of the Unichem Ghana Management Team.
President of the Dermatology Society, Dr. Alhaji Konney, and his General Secretary Dr. Mark – Young Seadey commended Unichem Ghana for their work in bringing safe and efficacious products like Mycolex Cream & Mycolex Powder to the Ghanian Market.
“Dermatologists meet patients on a daily basis who are worried about their skin and seek the right products to use. Mycolex Cream & Mycolex Powder is a time-proven anti-fungal, and has been used by myself and other professionals for almost two decades now. I can confidently say that this is one of safest and leading brands in the country used to treat a range of skin fungal infections.
“This accreditation will further boost confidence among doctors & dermatologists as they deliver healthcare to their patients,” explained Dr. Konney.
Mycolex Cream & Mycolex Powder are products of LUEX U.K., a British Pharmaceutical company that hase partnered exclusively with Unichem Ghana in West Africa for over 25 years and successfully established over 100 brands in the Ghanaian market.
The brand Mycolex is tested by dermatologists, scientists and microbiologists across the globe and is one of the market leaders in topical anti-fungal medication.
“With its easily recognisable badge, professionals and the public alike have gained confidence over the years and know that LUEX-accredited brands deliver safety, efficacy, quality and affordability,” explained Mr. Mohan, Chairman of the Unichem Ghana Group.
Over 300 million people worldwide are afflicted with a serious fungal infection every year.
